115 related articles for article (PubMed ID: 22309113)
1. Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease.
Jia W; Whitehead RN; Griffiths L; Dawson C; Bai H; Waring RH; Ramsden DB; Hunter JO; Cauchi M; Bessant C; Fowler DP; Walton C; Turner C; Cole JA
FEMS Immunol Med Microbiol; 2012 Jun; 65(1):55-68. PubMed ID: 22309113
[TBL] [Abstract][Full Text] [Related]
2. Sulfate-reducing bacteria in marine sediment (Aarhus Bay, Denmark): abundance and diversity related to geochemical zonation.
Leloup J; Fossing H; Kohls K; Holmkvist L; Borowski C; Jørgensen BB
Environ Microbiol; 2009 May; 11(5):1278-91. PubMed ID: 19220398
[TBL] [Abstract][Full Text] [Related]
3. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
[TBL] [Abstract][Full Text] [Related]
4. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
5. Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals.
Scanlan PD; Shanahan F; Marchesi JR
FEMS Microbiol Ecol; 2009 Aug; 69(2):213-21. PubMed ID: 19496818
[TBL] [Abstract][Full Text] [Related]
6. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.
Vigsnæs LK; Brynskov J; Steenholdt C; Wilcks A; Licht TR
Benef Microbes; 2012 Dec; 3(4):287-97. PubMed ID: 22968374
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bacterial community associated to biofilms of corroded oil pipelines from the southeast of Mexico.
Neria-González I; Wang ET; Ramírez F; Romero JM; Hernández-Rodríguez C
Anaerobe; 2006 Jun; 12(3):122-33. PubMed ID: 16765858
[TBL] [Abstract][Full Text] [Related]
8. Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells.
Coutinho CMLM; Coutinho-Silva R; Zinkevich V; Pearce CB; Ojcius DM; Beech I
Microb Pathog; 2017 Nov; 112():126-134. PubMed ID: 28963010
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sulphate-reducing bacterial communities in Japanese fish farm sediments with different levels of organic enrichment.
Kondo R; Mori Y; Sakami T
Microbes Environ; 2012; 27(2):193-9. PubMed ID: 22791053
[TBL] [Abstract][Full Text] [Related]
10. Carriage, quantification, and predominance of methanogens and sulfate-reducing bacteria in faecal samples.
Stewart JA; Chadwick VS; Murray A
Lett Appl Microbiol; 2006 Jul; 43(1):58-63. PubMed ID: 16834722
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease.
Kallinowski F; Wassmer A; Hofmann MA; Harmsen D; Heesemann J; Karch H; Herfarth C; Buhr HJ
Hepatogastroenterology; 1998; 45(23):1552-8. PubMed ID: 9840104
[TBL] [Abstract][Full Text] [Related]
13. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
[TBL] [Abstract][Full Text] [Related]
14. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the sulfate-reducing bacterial population associated with stored swine slurry.
Cook KL; Whitehead TR; Spence C; Cotta MA
Anaerobe; 2008 Jun; 14(3):172-80. PubMed ID: 18457964
[TBL] [Abstract][Full Text] [Related]
16. Identity and abundance of active sulfate-reducing bacteria in deep tidal flat sediments determined by directed cultivation and CARD-FISH analysis.
Gittel A; Mussmann M; Sass H; Cypionka H; Könneke M
Environ Microbiol; 2008 Oct; 10(10):2645-58. PubMed ID: 18627412
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and activity of sulphate reducing bacteria in aerobic activated sludge systems.
van den Brand TP; Roest K; Chen GH; Brdjanovic D; van Loosdrecht MC
World J Microbiol Biotechnol; 2015 Mar; 31(3):507-16. PubMed ID: 25649202
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut.
Gibson GR; Macfarlane GT; Cummings JH
J Appl Bacteriol; 1988 Aug; 65(2):103-11. PubMed ID: 3204069
[TBL] [Abstract][Full Text] [Related]
19. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.
Gosiewski T; Strus M; Fyderek K; Kowalska-Duplaga K; Wedrychowicz A; Jedynak-Wasowicz U; Sladek M; Pieczarkowski S; Adamski P; Heczko PB
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912
[TBL] [Abstract][Full Text] [Related]
20. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis.
Pitcher MC; Beatty ER; Cummings JH
Gut; 2000 Jan; 46(1):64-72. PubMed ID: 10601057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
